| Kyle Maclean, MD | |
|
440 W Interstate 635 #300, Irving, TX 75063 | |
| (214) 574-9600 | |
| Not Available |
| Full Name | Kyle Maclean |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 10 Years |
| Location | 440 W Interstate 635 #300, Irving, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053706184 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | S1447 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lasercare Eye Center Pa | 0143252130 | 3 |
| University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
According to research recently published by an Oregon Health & Science University scientist, a form of surgery called uvopalatopharyngoplasty is effective for treating certain patients who suffer from sleep apnea, one of the most common sleep disorders.
Transgenomic, Inc. announced today that its scientists have completed studies employing the company's high-sensitivity cancer mutation assays using two proprietary technologies, Ice COLD-PCR and BLOCker-Sequencing. Results from these studies will be presented at the American Association for Cancer Research meeting in Orlando, Florida, April 2-6, 2011.
Recently, the number of patients with GERD has increased in Japan. However, there have been few reports about the pathological findings in the esophageal squamous epithelium, and there are differing opinions among pathologists about the findings considered characteristic of chronic reflux esophagitis.
The Black AIDS Institute, with support from Merck, announced the launch of the Black Treatment Advocates Network. BTAN, the first collaborative Network of its kind, will train and mobilize a team of treatment advocates with a mission to link Black Americans with HIV into care and treatment; strengthen local and national leadership; raise HIV science and treatment literacy in Black communities; and advocate for policy change and research priorities.
Researchers have engineered an antibody that neutralizes SARS-CoV-2 with a potency that "rivals" current lead SARS-CoV-2 clinical neutralizing antibodies, and that also broadly neutralizes a range of clade 1 sarbecoviruses.
› Verified 8 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
According to research recently published by an Oregon Health & Science University scientist, a form of surgery called uvopalatopharyngoplasty is effective for treating certain patients who suffer from sleep apnea, one of the most common sleep disorders.
Transgenomic, Inc. announced today that its scientists have completed studies employing the company's high-sensitivity cancer mutation assays using two proprietary technologies, Ice COLD-PCR and BLOCker-Sequencing. Results from these studies will be presented at the American Association for Cancer Research meeting in Orlando, Florida, April 2-6, 2011.
Recently, the number of patients with GERD has increased in Japan. However, there have been few reports about the pathological findings in the esophageal squamous epithelium, and there are differing opinions among pathologists about the findings considered characteristic of chronic reflux esophagitis.
The Black AIDS Institute, with support from Merck, announced the launch of the Black Treatment Advocates Network. BTAN, the first collaborative Network of its kind, will train and mobilize a team of treatment advocates with a mission to link Black Americans with HIV into care and treatment; strengthen local and national leadership; raise HIV science and treatment literacy in Black communities; and advocate for policy change and research priorities.
Researchers have engineered an antibody that neutralizes SARS-CoV-2 with a potency that "rivals" current lead SARS-CoV-2 clinical neutralizing antibodies, and that also broadly neutralizes a range of clade 1 sarbecoviruses.
› Verified 8 days ago
| Entity Name | Lasercare Eye Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003911629 PECOS PAC ID: 0143252130 Enrollment ID: O20050910000251 |
News Archive
According to research recently published by an Oregon Health & Science University scientist, a form of surgery called uvopalatopharyngoplasty is effective for treating certain patients who suffer from sleep apnea, one of the most common sleep disorders.
Transgenomic, Inc. announced today that its scientists have completed studies employing the company's high-sensitivity cancer mutation assays using two proprietary technologies, Ice COLD-PCR and BLOCker-Sequencing. Results from these studies will be presented at the American Association for Cancer Research meeting in Orlando, Florida, April 2-6, 2011.
Recently, the number of patients with GERD has increased in Japan. However, there have been few reports about the pathological findings in the esophageal squamous epithelium, and there are differing opinions among pathologists about the findings considered characteristic of chronic reflux esophagitis.
The Black AIDS Institute, with support from Merck, announced the launch of the Black Treatment Advocates Network. BTAN, the first collaborative Network of its kind, will train and mobilize a team of treatment advocates with a mission to link Black Americans with HIV into care and treatment; strengthen local and national leadership; raise HIV science and treatment literacy in Black communities; and advocate for policy change and research priorities.
Researchers have engineered an antibody that neutralizes SARS-CoV-2 with a potency that "rivals" current lead SARS-CoV-2 clinical neutralizing antibodies, and that also broadly neutralizes a range of clade 1 sarbecoviruses.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Maclean, MD 440 W Interstate 635 #300, Irving, TX 75063 Ph: () - | Kyle Maclean, MD 440 W Interstate 635 #300, Irving, TX 75063 Ph: (214) 574-9600 |
News Archive
According to research recently published by an Oregon Health & Science University scientist, a form of surgery called uvopalatopharyngoplasty is effective for treating certain patients who suffer from sleep apnea, one of the most common sleep disorders.
Transgenomic, Inc. announced today that its scientists have completed studies employing the company's high-sensitivity cancer mutation assays using two proprietary technologies, Ice COLD-PCR and BLOCker-Sequencing. Results from these studies will be presented at the American Association for Cancer Research meeting in Orlando, Florida, April 2-6, 2011.
Recently, the number of patients with GERD has increased in Japan. However, there have been few reports about the pathological findings in the esophageal squamous epithelium, and there are differing opinions among pathologists about the findings considered characteristic of chronic reflux esophagitis.
The Black AIDS Institute, with support from Merck, announced the launch of the Black Treatment Advocates Network. BTAN, the first collaborative Network of its kind, will train and mobilize a team of treatment advocates with a mission to link Black Americans with HIV into care and treatment; strengthen local and national leadership; raise HIV science and treatment literacy in Black communities; and advocate for policy change and research priorities.
Researchers have engineered an antibody that neutralizes SARS-CoV-2 with a potency that "rivals" current lead SARS-CoV-2 clinical neutralizing antibodies, and that also broadly neutralizes a range of clade 1 sarbecoviruses.
› Verified 8 days ago
Dr. Sidney K Gicheru, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 440 W Lbj Freeway, Suite 300 Plaza Ii, Irving, TX 75063 Phone: 214-574-9600 Fax: 214-574-9601 | |
Subir S Bhatia, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 510 Ranch Trl, Suite 100, Irving, TX 75063 Phone: 972-899-8070 Fax: 972-899-8072 | |
Dr. David K Gregory, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 440 W Ih 635 Fwy, Suite 415, Irving, TX 75063 Phone: 972-254-4297 Fax: 972-254-9213 | |
Dr. Everett Albert Moody, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3200 N Macarthur Blvd, Ste 200, Irving, TX 75062 Phone: 972-258-7979 Fax: 972-570-5502 | |
Robert R Whitaker, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2001 N Macarthur Blvd, Ste 425, Irving, TX 75061 Phone: 972-253-2520 Fax: 972-254-0952 | |
Dr. Andrew Bradford Pazandak, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3100 N Macarthur Blvd, Irving, TX 75062 Phone: 972-258-6400 Fax: 972-570-1103 |